Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.
Vaccinia virus (VACV), the prototype poxvirus, encodes numerous proteins that modulate the host response to infection. Two such proteins, B14 and A52, act inside infected cells to inhibit activation of NF-kappaB, thereby blocking the production of pro-inflammatory cytokines. We have solved the cryst...
Những tác giả chính: | Graham, S, Bahar, M, Cooray, S, Chen, R, Whalen, D, Abrescia, N, Alderton, D, Owens, R, Stuart, D, Smith, G, Grimes, J |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Public Library of Science
2008
|
Những quyển sách tương tự
-
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.
Bằng: Stephen C Graham, et al.
Được phát hành: (2008-08-01) -
Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB.
Bằng: Benfield, C, et al.
Được phát hành: (2011) -
Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
Bằng: Bahar Miraghazadeh, et al.
Được phát hành: (2018-04-01) -
NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.
Bằng: Smith, C, et al.
Được phát hành: (2001) -
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
Bằng: Andreakos, E, et al.
Được phát hành: (2006)